Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Melanoma 1

Interventions

Nivolumab 19pembrolizumab 17Ipilimumab 13Specimen Handling 12Magnetic Resonance Spectroscopy 7CTLA-4 Antigen 6binimetinib 5Opdualag 5trametinib 4relatlimab 4dabrafenib 3Standard of Care 3Paclitaxel 3Introns 3Interferon alpha-2 3Gemcitabine 3Blood Specimen Collection 3ulixertinib 2sargramostim 2lenvatinib 2fludarabine phosphate 2fludarabine 2encorafenib 2capivasertib 2cabozantinib 2atezolizumab 2aldesleukin 2X-Rays 2Taxes 2Radiosurgery 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Melanoma × CBLC137 × 30 days × Clear all
NCT05498792 2026-05-22

Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma

Fox Chase Cancer Center

Phase EARLY_PHASE1 Recruiting
12 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡